IlDong Pharmaceutical Co Ltd
PharmaSeoul, South Korea, South Korea · Est. 1969
IlDong Pharmaceutical Co Ltd is a South Korean pharmaceutical company engaged in the development, manufacturing, and distribution of prescription and over-the-counter pharmaceutical products.
0
Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
0
Indications↗
Distinct diseases across all programs
39
Clinical Trials↗
All sponsored trials (all statuses)
Activity
Key Events
Nov 13, 2024TrialSafety, Tolerability, Pharmacokinetics and Pharmacodynamics of ID110521156 in Healthy Adult Subjects
Nov 20, 2023TrialSingle Ascending Oral Dose Phase 1 Study of ID110521156 in Healthy Adult Subjects
Dec 7, 2022TrialSafety, Tolerability, Pharmacokinetic and Pharmacodynamic of ID120040002 in Healthy Volunteers
Oct 10, 2022TrialSafety, Tolerability, and Pharmacokinetics of ID119031166M With the Exploration of Pharmacodynamic Effects
Jul 7, 2021TrialIDG-16177 for the Evaluation of Its Safety and Pharmacokinetics
Mar 24, 2020TrialLasmiditan Compared to Placebo in the Acute Treatment of Migraine in Korean
Feb 13, 2020TrialPharmacokinetics of Besifovir in Adults With Normal and Impaired Renal Function
Aug 1, 2019TrialStudy to Evaluate Pharmacokinetics, Safety, and Tolerability Ildong COL-144 Tablet in Korean Healthy Volunteers
4 more events
May 29, 2019TrialSwitching From Tenofovir Disoproxil Fumarate to Besifovir Dipivoxil Maleate
Jan 13, 2019TrialA Food Effect Study of Besifovir in Healthy Subjects
Sep 23, 2018TrialStudy to Assess Efficacy of Besifovir and L-carnitine in Chronic Hepatitis B Patients With Nonalcoholic Fatty Liver
Oct 1, 2016TrialCompare the Pharmacokinetics of TAH(80/10/12.5) Tablet in Comparison to the Co-administration of Telmisartan, Amlodipine and Hydrochlorothiazide in Healthy Male Volunteers
Details
Company Info
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Therapeutic Focus
GastrointestinalCardiovascularRespiratory
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)